Do analysts prefer RUBI or SQZ?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rubico 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SQZ Biotechnologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher valuation and earnings, RUBI or SQZ?

Rubico has higher revenue and earnings than SQZ Biotechnologies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Rubico $23.52M 0.06 $2.64M N/A N/A SQZ Biotechnologies $18.16M 0.04 -$79.46M -$2.61 N/A

Do analysts rate JYD or SQZ?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jayud Global Logistics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SQZ Biotechnologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger valuation & earnings, JYD or SQZ?

Jayud Global Logistics has higher revenue and earnings than SQZ Biotechnologies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Jayud Global Logistics $85.47M 0.04 -$5.07M N/A N/A SQZ Biotechnologies $18.16M 0.04 -$79.46M -$2.61 N/A

Do analysts rate SGLY or SQZ?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Singularity Future Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SQZ Biotechnologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts rate CISS or SQZ?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score C3is 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 SQZ Biotechnologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable valuation and earnings, CISS or SQZ?

C3is has higher revenue and earnings than SQZ Biotechnologies. SQZ Biotechnologies is trading at a lower price-to-earnings ratio than C3is, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio C3is $34.76M 0.01 $10.47M -$1.13 thousand N/A SQZ Biotechnologies $18.16M 0.04 -$79.46M -$2.61 N/A

Is CISS or SQZ more profitable?

C3is has a net margin of 15.28% compared to SQZ Biotechnologies' net margin of -369.96%. C3is' return on equity of 6.78% beat SQZ Biotechnologies' return on equity. Company Net Margins Return on Equity Return on Assets C3is 15.28% 6.78% 6.16% SQZ Biotechnologies -369.96% -119.83% -59.90%

SQZ Biotechnologies (SQZ) Competitors

$0.02 0.00 (0.00%)

As of 07/24/2026

Compare

SQZ vs. RUBI, JYD, SGLY, CISS, and USDP

Should you buy SQZ Biotechnologies stock or one of its competitors? MarketBeat compares SQZ Biotechnologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with SQZ Biotechnologies include Rubico (RUBI), Jayud Global Logistics (JYD), Singularity Future Technology (SGLY), C3is (CISS), and USD Partners (USDP). These companies are all part of the "transportation" industry.

How does SQZ Biotechnologies compare to Rubico?

Rubico (NASDAQ:RUBI) and SQZ Biotechnologies (NYSE:SQZ) are both small-cap transportation companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

In the previous week, Rubico had 6 more articles in the media than SQZ Biotechnologies. MarketBeat recorded 6 mentions for Rubico and 0 mentions for SQZ Biotechnologies. Rubico's average media sentiment score of 0.81 beat SQZ Biotechnologies' score of 0.00 indicating that Rubico is being referred to more favorably in the media.

Company	Overall Sentiment
Rubico	Positive
SQZ Biotechnologies	Neutral

38.5% of SQZ Biotechnologies shares are held by institutional investors. 16.0% of SQZ Biotechnologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rubico	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
SQZ Biotechnologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Rubico has a net margin of 0.00% compared to SQZ Biotechnologies' net margin of -369.96%. Rubico's return on equity of 0.00% beat SQZ Biotechnologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rubico	N/A	N/A	N/A
SQZ Biotechnologies	-369.96%	-119.83%	-59.90%

Rubico has higher revenue and earnings than SQZ Biotechnologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rubico	$23.52M	0.06	$2.64M	N/A	N/A
SQZ Biotechnologies	$18.16M	0.04	-$79.46M	-$2.61	N/A

Summary

Rubico beats SQZ Biotechnologies on 9 of the 11 factors compared between the two stocks.

How does SQZ Biotechnologies compare to Jayud Global Logistics?

Jayud Global Logistics (NASDAQ:JYD) and SQZ Biotechnologies (NYSE:SQZ) are both small-cap transportation companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, risk, dividends, media sentiment and institutional ownership.

Jayud Global Logistics has higher revenue and earnings than SQZ Biotechnologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jayud Global Logistics	$85.47M	0.04	-$5.07M	N/A	N/A
SQZ Biotechnologies	$18.16M	0.04	-$79.46M	-$2.61	N/A

In the previous week, Jayud Global Logistics had 3 more articles in the media than SQZ Biotechnologies. MarketBeat recorded 3 mentions for Jayud Global Logistics and 0 mentions for SQZ Biotechnologies. Jayud Global Logistics' average media sentiment score of 1.44 beat SQZ Biotechnologies' score of 0.00 indicating that Jayud Global Logistics is being referred to more favorably in the media.

Company	Overall Sentiment
Jayud Global Logistics	Positive
SQZ Biotechnologies	Neutral

Jayud Global Logistics has a beta of -1.48, suggesting that its stock price is 248% less volatile than the broader market. Comparatively, SQZ Biotechnologies has a beta of 2.34, suggesting that its stock price is 134% more volatile than the broader market.

67.9% of Jayud Global Logistics shares are held by institutional investors. Comparatively, 38.5% of SQZ Biotechnologies shares are held by institutional investors. 16.0% of SQZ Biotechnologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Jayud Global Logistics has a net margin of 0.00% compared to SQZ Biotechnologies' net margin of -369.96%. Jayud Global Logistics' return on equity of 0.00% beat SQZ Biotechnologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jayud Global Logistics	N/A	N/A	N/A
SQZ Biotechnologies	-369.96%	-119.83%	-59.90%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jayud Global Logistics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
SQZ Biotechnologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Jayud Global Logistics beats SQZ Biotechnologies on 9 of the 12 factors compared between the two stocks.

How does SQZ Biotechnologies compare to Singularity Future Technology?

Singularity Future Technology (NASDAQ:SGLY) and SQZ Biotechnologies (NYSE:SQZ) are both small-cap transportation companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, media sentiment, risk, profitability, analyst recommendations and dividends.

Singularity Future Technology has a beta of 1.61, indicating that its stock price is 61% more volatile than the broader market. Comparatively, SQZ Biotechnologies has a beta of 2.34, indicating that its stock price is 134% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Singularity Future Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
SQZ Biotechnologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

SQZ Biotechnologies has a net margin of -369.96% compared to Singularity Future Technology's net margin of -493.25%. Singularity Future Technology's return on equity of -42.68% beat SQZ Biotechnologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Singularity Future Technology	-493.25%	-42.68%	-13.00%
SQZ Biotechnologies	-369.96%	-119.83%	-59.90%

4.1% of Singularity Future Technology shares are owned by institutional investors. Comparatively, 38.5% of SQZ Biotechnologies shares are owned by institutional investors. 10.2% of Singularity Future Technology shares are owned by company insiders. Comparatively, 16.0% of SQZ Biotechnologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Singularity Future Technology has higher earnings, but lower revenue than SQZ Biotechnologies. Singularity Future Technology is trading at a lower price-to-earnings ratio than SQZ Biotechnologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Singularity Future Technology	$1.81M	0.62	-$3.91M	-$1.77	N/A
SQZ Biotechnologies	$18.16M	0.04	-$79.46M	-$2.61	N/A

In the previous week, Singularity Future Technology had 3 more articles in the media than SQZ Biotechnologies. MarketBeat recorded 3 mentions for Singularity Future Technology and 0 mentions for SQZ Biotechnologies. SQZ Biotechnologies' average media sentiment score of 0.00 beat Singularity Future Technology's score of -0.38 indicating that SQZ Biotechnologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Singularity Future Technology	Neutral
SQZ Biotechnologies	Neutral

Summary

Singularity Future Technology and SQZ Biotechnologies tied by winning 7 of the 14 factors compared between the two stocks.

How does SQZ Biotechnologies compare to C3is?

C3is (NASDAQ:CISS) and SQZ Biotechnologies (NYSE:SQZ) are both small-cap transportation companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment and valuation.

C3is has a net margin of 15.28% compared to SQZ Biotechnologies' net margin of -369.96%. C3is' return on equity of 6.78% beat SQZ Biotechnologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
C3is	15.28%	6.78%	6.16%
SQZ Biotechnologies	-369.96%	-119.83%	-59.90%

C3is has higher revenue and earnings than SQZ Biotechnologies. SQZ Biotechnologies is trading at a lower price-to-earnings ratio than C3is, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
C3is	$34.76M	0.01	$10.47M	-$1.13 thousand	N/A
SQZ Biotechnologies	$18.16M	0.04	-$79.46M	-$2.61	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
C3is	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
SQZ Biotechnologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, C3is had 3 more articles in the media than SQZ Biotechnologies. MarketBeat recorded 3 mentions for C3is and 0 mentions for SQZ Biotechnologies. C3is' average media sentiment score of 0.30 beat SQZ Biotechnologies' score of 0.00 indicating that C3is is being referred to more favorably in the media.

Company	Overall Sentiment
C3is	Neutral
SQZ Biotechnologies	Neutral

C3is has a beta of 1.28, indicating that its stock price is 28% more volatile than the broader market. Comparatively, SQZ Biotechnologies has a beta of 2.34, indicating that its stock price is 134% more volatile than the broader market.

10.5% of C3is shares are held by institutional investors. Comparatively, 38.5% of SQZ Biotechnologies shares are held by institutional investors. 16.0% of SQZ Biotechnologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

C3is beats SQZ Biotechnologies on 9 of the 14 factors compared between the two stocks.

How does SQZ Biotechnologies compare to USD Partners?

SQZ Biotechnologies (NYSE:SQZ) and USD Partners (NYSE:USDP) are both small-cap transportation companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

USD Partners has a net margin of -94.39% compared to SQZ Biotechnologies' net margin of -369.96%. USD Partners' return on equity of 0.00% beat SQZ Biotechnologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SQZ Biotechnologies	-369.96%	-119.83%	-59.90%
USD Partners	-94.39%	N/A	-28.33%

In the previous week, SQZ Biotechnologies' average media sentiment score of 0.00 equaled USD Partners'average media sentiment score.

Company	Overall Sentiment
SQZ Biotechnologies	Neutral
USD Partners	Neutral

38.5% of SQZ Biotechnologies shares are owned by institutional investors. Comparatively, 0.1% of USD Partners shares are owned by institutional investors. 16.0% of SQZ Biotechnologies shares are owned by insiders. Comparatively, 2.6% of USD Partners shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

SQZ Biotechnologies has a beta of 2.34, suggesting that its stock price is 134% more volatile than the broader market. Comparatively, USD Partners has a beta of -0.39, suggesting that its stock price is 139% less volatile than the broader market.

USD Partners has higher revenue and earnings than SQZ Biotechnologies. SQZ Biotechnologies is trading at a lower price-to-earnings ratio than USD Partners, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SQZ Biotechnologies	$18.16M	0.04	-$79.46M	-$2.61	N/A
USD Partners	$72.32M	0.00	$17.77M	-$1.06	N/A

Summary

USD Partners beats SQZ Biotechnologies on 7 of the 10 factors compared between the two stocks.

Get SQZ Biotechnologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SQZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SQZ vs. The Competition

Export

Metric	SQZ Biotechnologies	Biological Products Industry	Medical Sector	NYSE Exchange
Market Cap	$708K	$350.24M	$6.90B	$23.53B
Dividend Yield	N/A	N/A	2.67%	4.20%
P/E Ratio	-0.01	N/A	27.14	30.96
Price / Sales	0.04	228.84	523.34	19.25
Price / Cash	N/A	22.44	26.39	18.55
Price / Book	0.01	4.88	10.30	4.73
Net Income	-$79.46M	-$141.03M	$3.60B	$1.07B
7 Day Performance	N/A	-1.93%	-0.27%	-0.04%
1 Month Performance	N/A	-4.53%	-1.74%	-0.42%
1 Year Performance	N/A	41.88%	18.24%	14.22%

SQZ Biotechnologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SQZ SQZ Biotechnologies	N/A	$0.02 flat	N/A	N/A	$708K	$18.16M	N/A	1,620
RUBI Rubico	1.478 of 5 stars	$3.72 -13.1%	N/A	N/A	$2.59M	$23.52M	N/A	N/A	Positive News Short Interest Decrease Gap Down High Trading Volume
JYD Jayud Global Logistics	1.1069 of 5 stars	$0.75 +4.9%	N/A	-91.7%	$2.32M	$85.47M	N/A	175	News Coverage Positive News Short Interest Decrease
SGLY Singularity Future Technology	0.1957 of 5 stars	$0.27 +11.5%	N/A	-74.9%	$1.03M	$1.81M	N/A	40	Short Interest Increase Gap Up
CISS C3is	0.2768 of 5 stars	$1.68 +7.0%	N/A	-99.9%	$850K	$37.66M	N/A	N/A	Short Interest Increase Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:SQZ) was last updated on 7/27/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

SQZ Biotechnologies (SQZ) Competitors

SQZ vs. RUBI, JYD, SGLY, CISS, and USDP

How does SQZ Biotechnologies compare to Rubico?

Summary

How does SQZ Biotechnologies compare to Jayud Global Logistics?

Summary

How does SQZ Biotechnologies compare to Singularity Future Technology?

Summary

How does SQZ Biotechnologies compare to C3is?

Summary

How does SQZ Biotechnologies compare to USD Partners?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SQZ vs. The Competition

SQZ Biotechnologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

SQZ Biotechnologies (SQZ) Competitors

SQZ vs. RUBI, JYD, SGLY, CISS, and USDP

How does SQZ Biotechnologies compare to Rubico?

Does the media refer more to RUBI or SQZ?

Do institutionals & insiders hold more shares of RUBI or SQZ?

Do analysts prefer RUBI or SQZ?

Is RUBI or SQZ more profitable?

Which has higher valuation and earnings, RUBI or SQZ?

Summary

How does SQZ Biotechnologies compare to Jayud Global Logistics?

Which has stronger valuation & earnings, JYD or SQZ?

Does the media refer more to JYD or SQZ?

Which has more risk & volatility, JYD or SQZ?

Do institutionals & insiders hold more shares of JYD or SQZ?

Is JYD or SQZ more profitable?

Do analysts rate JYD or SQZ?

Summary

How does SQZ Biotechnologies compare to Singularity Future Technology?

Which has more volatility & risk, SGLY or SQZ?

Do analysts rate SGLY or SQZ?

Is SGLY or SQZ more profitable?

Do insiders & institutionals hold more shares of SGLY or SQZ?

Which has stronger valuation & earnings, SGLY or SQZ?

Does the media prefer SGLY or SQZ?

Summary

How does SQZ Biotechnologies compare to C3is?

Is CISS or SQZ more profitable?

Which has preferable valuation and earnings, CISS or SQZ?

Do analysts rate CISS or SQZ?

Does the media favor CISS or SQZ?

Which has more risk and volatility, CISS or SQZ?

Do insiders and institutionals believe in CISS or SQZ?

Summary

How does SQZ Biotechnologies compare to USD Partners?

Is SQZ or USDP more profitable?

Does the media refer more to SQZ or USDP?

Do insiders and institutionals hold more shares of SQZ or USDP?

Which has more volatility & risk, SQZ or USDP?

Which has preferable valuation & earnings, SQZ or USDP?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SQZ vs. The Competition

SQZ Biotechnologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools